Related Experiment Videos
Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis
Umur Hatipoğlu1, Israel Rubinstein
1Section of Respiratory and Critical Care Medicine, Department of Medicine, University of Illinois at Chicago, Chicago, Ill. 60616-7323, USA.
Respiration; International Review of Thoracic Diseases
|January 21, 2004
Summary
Obstructive sleep apnea syndrome (OSAS) involves local and systemic inflammation, contributing to cardiovascular issues. Treating inflammation may offer new therapeutic avenues for OSAS patients.
Area of Science:
- Sleep Medicine
- Cardiovascular Research
- Immunology
Background:
- Obstructive sleep apnea syndrome (OSAS) affects 5% of adults, linking to cardiovascular disease and diabetes.
- OSAS pathogenesis involves significant local and systemic inflammation.
- Inflammation may worsen upper airway narrowing and apnea severity.
Purpose of the Study:
- To explore the role of inflammation in OSAS.
- To investigate the link between systemic inflammation and cardiovascular complications in OSAS.
- To assess the impact of Continuous Positive Airway Pressure (CPAP) on inflammation.
Main Methods:
- Review of existing literature on OSAS, inflammation, and cardiovascular comorbidities.
- Analysis of inflammatory markers (e.g., C-reactive protein, TNF-alpha, IL-6) in OSAS patients.
- Evaluation of CPAP therapy's effects on inflammatory pathways.
Main Results:
- Elevated pro-inflammatory mediators are characteristic of OSAS.
- Systemic inflammation correlates with increased cardiovascular risk in OSAS.
- CPAP treatment partially reduces local and systemic inflammation.
Conclusions:
- Inflammation is a key factor in OSAS pathophysiology and its complications.
- Targeting inflammation could be a potential therapeutic strategy for OSAS.
- Further research is needed to confirm the efficacy of anti-inflammatory treatments as adjuncts to CPAP.